BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 34568024)

  • 1. Correction to "Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation".
    Int J Cancer; 2024 Jul; 155(1):E1. PubMed ID: 38520222
    [No Abstract]   [Full Text] [Related]  

  • 2. USP27X, a new player on EMT and fibroblast activation.
    Díaz VM
    Oncotarget; 2018 Dec; 9(95):36724-36725. PubMed ID: 30613357
    [No Abstract]   [Full Text] [Related]  

  • 3. TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization.
    Lin Y; Lv X; Sun C; Sun Y; Yang M; Ma D; Jing W; Zhao Y; Cheng Y; Xuan H; Han L
    EMBO Rep; 2022 Nov; 23(11):e54569. PubMed ID: 36178239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM50 Inhibits Proliferation and Metastasis of Gastric Cancer via Promoting
    Li R; Xu P; Jin X; Shi Z; Zhang Q; Ye F; Yu W; Ji T
    J Oncol; 2022; 2022():5936753. PubMed ID: 36046365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma.
    Zhang Q; Lv L; Ma P; Zhang Y; Deng J; Zhang Y
    Front Immunol; 2021; 12():743938. PubMed ID: 34956177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proteome-scale map of the SARS-CoV-2-human contactome.
    Kim DK; Weller B; Lin CW; Sheykhkarimli D; Knapp JJ; Dugied G; Zanzoni A; Pons C; Tofaute MJ; Maseko SB; Spirohn K; Laval F; Lambourne L; Kishore N; Rayhan A; Sauer M; Young V; Halder H; la Rosa NM; Pogoutse O; Strobel A; Schwehn P; Li R; Rothballer ST; Altmann M; Cassonnet P; Coté AG; Vergara LE; Hazelwood I; Liu BB; Nguyen M; Pandiarajan R; Dohai B; Coloma PAR; Poirson J; Giuliana P; Willems L; Taipale M; Jacob Y; Hao T; Hill DE; Brun C; Twizere JC; Krappmann D; Heinig M; Falter C; Aloy P; Demeret C; Vidal M; Calderwood MA; Roth FP; Falter-Braun P
    Nat Biotechnol; 2023 Jan; 41(1):140-149. PubMed ID: 36217029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
    Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
    Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP36 stabilizes nucleolar Snail1 to promote ribosome biogenesis and cancer cell survival upon ribotoxic stress.
    Qin K; Yu S; Liu Y; Guo R; Guo S; Fei J; Wang Y; Jia K; Xu Z; Chen H; Li F; Niu M; Dai MS; Dai L; Cao Y; Zhang Y; Xiao ZJ; Yi Y
    Nat Commun; 2023 Oct; 14(1):6473. PubMed ID: 37833415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP.
    Hu J; Huang R; Liang C; Wang Y; Wang M; Chen Y; Wu C; Zhang J; Liu Z; Zhao Q; Liu Z; Wang F; Yuan S
    Mol Cancer Res; 2023 Oct; 21(10):1107-1119. PubMed ID: 37409971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer.
    Ji Q; Li H; Cai Z; Yuan X; Pu X; Huang Y; Fu S; Chu L; Jiang C; Xue J; Zhang X; Li R
    Int J Biol Sci; 2023; 19(6):1894-1909. PubMed ID: 37063425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62.
    Zhang K; Li YJ; Peng LJ; Gao HF; Liu LM; Chen H
    Biol Direct; 2023 Jan; 18(1):1. PubMed ID: 36631876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer illumination of TRIM gene family reveals immunology regulation and potential therapeutic implications.
    Gao Y; Pan T; Xu G; Li S; Guo J; Zhang Y; Xu Q; Pan J; Ma Y; Xu J; Li Y
    Hum Genomics; 2022 Dec; 16(1):65. PubMed ID: 36461099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM family contribute to tumorigenesis, cancer development, and drug resistance.
    Huang N; Sun X; Li P; Liu X; Zhang X; Chen Q; Xin H
    Exp Hematol Oncol; 2022 Oct; 11(1):75. PubMed ID: 36261847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles and targeting options of TRIM family proteins in tumor.
    Zhang Y; Zhang W; Zheng L; Guo Q
    Front Pharmacol; 2022; 13():999380. PubMed ID: 36249749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM50 Suppresses Pancreatic Cancer Progression and Reverses the Epithelial-Mesenchymal Transition
    Li R; Zhu L; Peng Y; Zhang X; Dai C; Liu D
    Front Oncol; 2021; 11():695740. PubMed ID: 34568024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation.
    Ma X; Ma X; Qiu Y; Zhu L; Lin Y; You Y; Ma D; Qin Z; Sun C; Zhao Y; Sun Y; Han L
    Cell Death Dis; 2018 May; 9(6):608. PubMed ID: 29789583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM50 acts as a novel Src suppressor and inhibits ovarian cancer progression.
    Qiu Y; Liu P; Ma X; Ma X; Zhu L; Lin Y; You Y; Yu W; Ma D; Sun C; Qin Z; Zhao Y; Shi J; Han L
    Biochim Biophys Acta Mol Cell Res; 2019 Sep; 1866(9):1412-1420. PubMed ID: 31176697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXO31 Suppresses Gastric Cancer EMT by Targeting Snail1 for Proteasomal Degradation.
    Zou S; Ma C; Yang F; Xu X; Jia J; Liu Z
    Mol Cancer Res; 2018 Feb; 16(2):286-295. PubMed ID: 29117943
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.